12 research outputs found
Variations in plasma lipids and lipoproteins among cardiovascular disease patients in South-western Nigerians
This study was designed to assess the changes in plasma lipids and
lipoproteins, in particular high-density lipoprotein (HDLC) in patients
suffering from different types of cardiovascular disease (CVD) in
South-western Nigeria. Patients were drawn from different socioeconomic
classes in order to determine the effect of this factor on CVD in
Nigeria. One hundred and seventy (74 males, 96 females) CVD patients
(hypertensive heart disease (n=48), hypertension (n=59), ischaemic
heart disease (n=49), myocardial infarction (n=4)) with a mean age of
45.3\ub113.2 years were selected. Fifty-eight individuals (31 males
and 27 female) with mean age of 44.8\ub111.7 years were included as
controls. Result showed significant increases in mean plasma total
cholesterol (TC) (P < 0.05), triglyceride and low density
lipoproteins (LDLC) (P < 0.01), LDLC: HDLC (p < 0.001), as well
as in systolic and diastolic blood pressures (p < 0.001), while
plasma HDLC (p < 0.01) and HDLC:TC (p < 0.001) showed significant
decreases when compared with the corresponding mean control values.
There were graded decreases in plasma HDLC in the different
socioeconomic classes. The lowest mean plasma HDLC was found in IHD
patients. This study has uncovered variations in plasma lipids and
lipoproteins among patients of CVD within the different socioeconomic
classes in South-western Nigeria
Blood pressure control and left ventricular hypertrophy in hypertensive Nigerians
Background : Hypertension is a disease characterized by end-organ
complications, leading to high morbidity and mortality in many cases.
People with untreated or uncontrolled hypertension often run the risk
of developing complications directly associated with the disease. Left
ventricular hypertrophy (LVH) has been shown to be a significant risk
factor for adverse outcomes both in patients with hypertension and in
the general population. We investigated the prevalence and pattern of
LVH in a treated hypertensive population at the University College
Hospital, Ibadan, Nigeria, using non-hypertensive subjects as control.
Design and Setting : A prospective observational study performed at the
University College Hospital, Ibadan, Nigeria. Methods : Patients had 6
visits, when at least one blood pressure measurement was recorded for
each hypertensive subject and average calculated for systolic blood
pressure (SBP) and diastolic blood pressure (DBP) separately. The
values obtained were used for stratification of the subjects into
controlled and uncontrolled hypertension. Subjects also had
echocardiograms to determine their left ventricular mass. Results :
LVH was found in 14 (18.2%) of the normotensive group, 40 (20.8%) of
the uncontrolled hypertensive group and 14 (24.1%) of the controlled
hypertensive group when left ventricular mass (LVM) was indexed to body
surface area (BSA). When LVM was indexed to height, left ventricular
hypertrophy was found in none of the subjects of the normotensive
group, while it was found present in 43 (22.4%) and 14 (24.1%) subjects
of the uncontrolled and controlled hypertensive groups, respectively.
Significant difference in the prevalence of LVH was detected only when
LVM was indexed to height alone. Conclusion : Clinic blood pressure is
an ineffective way of assessing BP control. Thus in apparently
controlled hypertensive subjects, based on office blood pressure,
cardiac structural changes do remain despite antihypertensive therapy.
This population is still at risk of cardiovascular events.arri\ue8re-plan: l\u2019hypertension est une maladie
caract\ue9ris\ue9e par l\u2019orgue de fi n complications menant
\ue0 \ue9lev\ue9 de morbidit\ue9 et mortalit\ue9 dans de
nombreux cas. Personnes avec l\u2019hypertension non trait\ue9e ou
non contr\uf4l\ue9e souvent risquent de d\ue9velopper
complications directement associ\ue9es \ue0 la maladie. Laiss\ue9
ventriculaire hypertrophie (LVH) a \ue9t\ue9 d\ue9montr\ue9 un
facteur de risque signifi catif pour les effets n\ue9gatifs
r\ue9sultats tant chez les patients atteints de l\u2019hypertension
et de la population g\ue9n\ue9rale. Nous avons a enqu\ueat\ue9
sur la pr\ue9valence et le mod\ue8le de LVH dans un trait\ue9
hypertendues population au University College Hospital, \ue0
l\u2019aide Ibadan, Nigeria non-hypertendues des sujets comme
contr\uf4le. conception et la confi guration: A \ue9ventuel
\ue9tude d\u2019observation effectu\ue9e \ue0 la University
College Hospital, Ibadan, Nigeria. m\ue9thodes: Patients avaient six
visites o\uf9 au moins un sang mesure de pression a \ue9t\ue9
enregistr\ue9e pour chaque sujet hypertendues et moyenne
calcul\ue9s s\ue9par\ue9ment pour SBP et DBP. Les valeurs
obtenues ont \ue9t\ue9 utilis\ue9es pour stratifi cation des
sujets dans l\u2019hypertension contr\uf4l\ue9e et
incontr\uf4l\ue9e. Sujets ont \ue9galement echocardiograms pour
d\ue9terminer leur masse ventriculaire gauche. r\ue9sultats: LVH a
\ue9t\ue9 trouv\ue9 en 14(18.2%) de la groupe normotensive,
40(20.8%) de groupe de hypertendues non contr\uf4l\ue9es et
14(24.1%) de hypertendues contr\uf4l\ue9e groupe lorsque
quitt\ue9 masse ventriculaire (LVM) a \ue9t\ue9 index\ue9e
\ue0 corps surface (BSA). Lorsque LVM a \ue9t\ue9 index\ue9
\ue0 hauteur, laiss\ue9 ventriculaire hypertrophie a \ue9t\ue9
trouv\ue9 dans aucun du groupe normotensive, bien qu\u2019il a
\ue9t\ue9 constat\ue9 pr\ue9sents dans les 43(22.4%) et
14(24.1%) de hypertendues non ma\ueetris\ue9e et
contr\uf4l\ue9e groupes respectivement. \uc9tait de
diff\ue9rence signifi cative dans la pr\ue9valence de la LVH
d\ue9tect\ue9s uniquement lorsque LVM a \ue9t\ue9 index\ue9
\ue0 hauteur alone. conclusion: clinique art\ue9rielle est un moyen
ineffi cace de mesurer le contr\uf4le de BP. Ainsi en sujet
hypertendues apparemment contr\uf4l\ue9e bas\ue9e sur la pression
art\ue9rielle de bureau, des changements structurels cardiaques
restent malgr\ue9 th\ue9rapie antihypertensive. Cette population
est toujours \ue0 risque de maladies cardiovasculaires
\ue9v\ue9nements
Echocardiographic partition values and prevalence of left ventricular hypertrophy in hypertensive Nigerians
BACKGROUND: Left ventricular hypertrophy (LVH) is a well known independent risk factor for cardiovascular events. It has been shown that combination of left ventricular mass (LVM) and relative wall thickness (RWT) can be used to identify different forms of left ventricular (LV) geometry. Prospective studies have shown that LV geometric patterns have prognostic implications, with the worst prognosis associated with concentric hypertrophy. The methods for the normalization or indexation of LVM have also recently been shown to confer some prognostic value especially in obese population. We sought to determine the prevalence of echocardiographic lLVH using eight different and published cut-off or threshold values in hypertensive subjects seen in a developing country's tertiary centre. METHODS: Echocardiography was performed in four hundred and eighty consecutive hypertensive subjects attending the cardiology clinic of the University college Hospital Ibadan, Nigeria over a two-year period. RESULTS: Complete data was obtained in 457 (95.2%) of the 480 subjects (48.6% women). The prevalence of LVH ranged between 30.9–56.0%. The highest prevalence was when LVM was indexed to the power of 2.7 with a partition value of 49.2 g/ht(2.7 )in men and 46.7 g/ht(2.7 )in women. The lowest prevalence was observed when LVM was indexed to body surface area (BSA) and a partition value of 125 g/m(2 )was used for both sexes. Abnormal LV geometry was present in 61.1%–74.0% of our subjects and commoner in women. CONCLUSION: The prevalence of LVH hypertensive patients is strongly dependent on the cut-off value used to define it. Large-scale prospective study will be needed to determine the prognostic implications of the different LV geometry in native Africans
Characterisation of heart failure with normal ejection fraction in a tertiary hospital in Nigeria
<p>Abstract</p> <p>Background</p> <p>The study aimed to determine the frequency and characteristics of heart failure with normal EF in a native African population with heart failure.</p> <p>Methods</p> <p>It was a hospital cohort study. Subjects were 177 consecutive individuals with heart failure and ninety apparently normal control subjects. All the subjects underwent transthoracic echocardiography. The group with heart failure was further subdivided into heart failure with normal EF (EF ≥ 50) (HFNEF) and heart failure with low EF(EF <50)(HFLEF).</p> <p>Results</p> <p>The subjects with heart failure have a mean age of 52.3 ± 16.64 years vs 52.1 ± 11.84 years in the control subjects; p = 0.914. Other baseline characteristics except blood pressure parameters and height were comparable between the group with heart failure and the control subjects. The frequency of HFNEF was 39.5%. Compared with the HFLEF group, the HFNEF group have a smaller left ventricular diameter (in diastole and systole): (5.2 ± 1.22 cm vs 6.2 ± 1.39 cm; p < 0.0001 and 3.6 ± 1.24 cm vs 5.4 ± 1.35 cm;p < 0.0001) respectively, a higher relative wall thickness and deceleration time of the early mitral inflow velocity: (0.4 ± 0.12 vs 0.3 ± 0.14 p < 0.0001 and 149.6 ± 72.35 vs 110.9 ± 63.40 p = 0.001) respectively.</p> <p>The two groups with heart failure differed significantly from the control subjects in virtually all echocardiographic measurements except aortic root diameter, LV posterior wall thickness(HFLEF), and late mitral inflow velocity(HFNEF). HFNEF accounted for 70(39.5%) of cases of heart failure in this study.</p> <p>Hypertension is the underlying cardiovascular disease in 134(75.7%) of the combined heart failure population, 58 (82.9%) of the subjects with HFNEF group and 76(71%) of the HFLEF group. Females accounted for 44 (62.9%) of the subjects with HFNEF against 42(39.3%) in the HFLEF group (p = 0.002).</p> <p>Conclusion</p> <p>The frequency of heart failure with normal EF in this native African cohort with heart failure is comparable with the frequency in other populations. These groups of patients are more likely female, hypertensive with concentric pattern of left ventricular hypertrophy.</p
May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension
Aims
Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide and fewer than half of those with hypertension are aware of it. May Measurement Month (MMM) is a global campaign set up in 2017, to raise awareness of high BP and as a pragmatic solution to a lack of formal screening worldwide. The 2018 campaign was expanded, aiming to include more participants and countries.
Methods and results
Eighty-nine countries participated in MMM 2018. Volunteers (≥18 years) were recruited through opportunistic sampling at a variety of screening sites. Each participant had three BP measurements and completed a questionnaire on demographic, lifestyle, and environmental factors. Hypertension was defined as a systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg, or taking antihypertensive medication. In total, 74.9% of screenees provided three BP readings. Multiple imputation using chained equations was used to impute missing readings. 1 504 963 individuals (mean age 45.3 years; 52.4% female) were screened. After multiple imputation, 502 079 (33.4%) individuals had hypertension, of whom 59.5% were aware of their diagnosis and 55.3% were taking antihypertensive medication. Of those on medication, 60.0% were controlled and of all hypertensives, 33.2% were controlled. We detected 224 285 individuals with untreated hypertension and 111 214 individuals with inadequately treated (systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg) hypertension.
Conclusion
May Measurement Month expanded significantly compared with 2017, including more participants in more countries. The campaign identified over 335 000 adults with untreated or inadequately treated hypertension. In the absence of systematic screening programmes, MMM was effective at raising awareness at least among these individuals at risk
Variations in plasma lipids and lipoproteins among cardiovascular disease patients in South-western Nigerians
This study was designed to assess the changes in plasma lipids and
lipoproteins, in particular high-density lipoprotein (HDLC) in patients
suffering from different types of cardiovascular disease (CVD) in
South-western Nigeria. Patients were drawn from different socioeconomic
classes in order to determine the effect of this factor on CVD in
Nigeria. One hundred and seventy (74 males, 96 females) CVD patients
(hypertensive heart disease (n=48), hypertension (n=59), ischaemic
heart disease (n=49), myocardial infarction (n=4)) with a mean age of
45.3±13.2 years were selected. Fifty-eight individuals (31 males
and 27 female) with mean age of 44.8±11.7 years were included as
controls. Result showed significant increases in mean plasma total
cholesterol (TC) (P < 0.05), triglyceride and low density
lipoproteins (LDLC) (P < 0.01), LDLC: HDLC (p < 0.001), as well
as in systolic and diastolic blood pressures (p < 0.001), while
plasma HDLC (p < 0.01) and HDLC:TC (p < 0.001) showed significant
decreases when compared with the corresponding mean control values.
There were graded decreases in plasma HDLC in the different
socioeconomic classes. The lowest mean plasma HDLC was found in IHD
patients. This study has uncovered variations in plasma lipids and
lipoproteins among patients of CVD within the different socioeconomic
classes in South-western Nigeria
Left ventricular geometric patterns in newly presenting nigerian hypertensives: An echocardiographic study
Abstract Background Hypertension is a global problem and it is prevalent in Nigeria. Left ventricular hypertrophy is a major complication of hypertension with risk of sudden death and arrhythmias among others. Abnormal left ventricular geometric patterns also increase the burden of morbidity and mortality. It is therefore important to know the different left ventricular geometric patterns in Nigerian hypertensives because of their prognostic significance. Methods One hundred (100) newly presenting hypertensives (53 males and 47 females) and 100 controls (53 males and 47 females) were recruited for the study. All were subjected to clinical evaluation and full echocardiographic examination was performed according to the ASE recommendation. The relative wall thickness and the presence or absence of echocardiographic left ventricular hypertrophy were used to determine the various geometric patterns Results The mean age of the hypertensive subjects was 56.06 (± 7.68) years while that of the control subjects was 56.10 (± 7.68) years. There was no significant difference in the mean ages of the two groups. In the hypertensive subjects 28% had normal geometry, 26% had concentric remodeling, 28% had concentric hypertrophy and 18% had eccentric hypertrophy. In the control group, 86% had normal geometry, 11% had concentric remodeling, 3% had eccentric hypertrophy and none had concentric hypertrophy. There was statistical significance when the geometric patterns of the hypertensive and controls were compared (χ2 = 74.30, p value Conclusion The study showed that only 28% of the hypertensive subjects had normal LV geometric pattern while 86% of the normal subjects had normal geometry. There is need for longitudinal studies in order to prognosticate the various geometric patterns.</p